Innovation is added value to a known process. Bioprinting: Techniques and Risks for Regenerative Medicine aims to stimulate a scientifically grounded, interdisciplinary, multiscale debate and exchange of ideas using the techniques described in the book. 3D printing and additive manufacturing evolved from within the field of Cell Biology will have the ability to recreate cells queried from large amounts of phenotypic and molecular data. Stem Cell biologists, biotechnologists and material engineers, as well as graduate students will greatly benefit from the practical knowledge and case examples provided throughout this book.
- Shows the possible risk of rejection of 3D printed cells.
- Contains bioprinting techniques in literature plus actual 3D files adapted and created by the author using several types of 3d printers
- Provides information on how to convert an existing 3-D printer to bioprinter using currently available techniques
- Describes the increased complexity of bioprinting compared to 3D- printing
- Discussion on how 3D printing and additive manufacturing offers the opportunity to 3D print an entire organ, reducing the associated costs of this process when using cells as bioink
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
1. Biomanufacturing: The Definition and Evolution of a New Genre 2. Reproducing Cells Is Nothing New-A Historical Prospective 3. Bioprinting Versus 3D Printing 4. Bioprinters in Use Today 5. Materials for Use in Bioprinting 6. CT Scans Function Like a CAD Design 7. Additive Manufacturing and 3D Bioprinting for Pharmaceutical Testing 8. Advances in Personalized Medicine: Bioprinted Tissues and Organs
The lead scientist and principle author in numerous studies involving tumor immunology, Dr. Mitchell has current teaching experience in anatomy and physiology, including recognition for contributions to research development, revenue-focused product development and management of high-tech operations. She is a contributor to the NCBI SNP database for pediatirc and urological cancers.
Dr. Mitchell has been a research scientist for well over 17 years in the biomedical field, most recently as Senior Director of Research & Development in Greater New York conducting flow cytometry and molecular-based assays in conjunction with bioinformatics.